Transforming Precision Therapies Through Robust Liquid Biopsy Testing

Address Translational & Commercial Challenges to Seamlessly Utilize Liquid Biopsy Technologies to Drive Smarter, Accelerated Oncology Drug Development

Next week, join the 10th Liquid Biopsy for Precision Oncology Summit, the leading annual meeting uniting pharma, biotech, diagnostics, consortia, academia and patient voices to accelerate collaboration and progress in the rapidly advancing field of liquid biopsy.

Now in its 10th year, this meeting will deliver unparalleled insights, data, technology updates, and strategies spanning the entire drug development pipeline - from preclinical discovery, through clinical translation, to regulatory approval, reimbursement, and commercial adoption.

If you are working in precision oncology, or need enhanced insights into your patient population, optimized diagnostic and prognostic tools, or earlier detection of disease, this meeting should be considered a staple entry in your conference calendar. Across ctDNA, MRD, multi-omic biomarkers, and novel analytes, you will see how pharma are strategically integrating liquid biopsies into therapeutic pipelines, how diagnostic companies are designing more sensitive assays, and how the field is overcoming barriers to widespread clinical adoption.

What’s more?
Tickets are complimentary* for biopharma.

A great mix of cutting edge scientist and vendors, pharma, and clinical presentations. It was very valuable to help me keep up in this constantly updating field and both share my work and learn from others.

Past Speaker, Director – Computational Biology, Lantern Pharma

An excellent conference. It was a good mix of topics broadly relevant to the community covered in plenary sessions, more specialized options in two parallel tracks, and easy access to exhibitors.

Past Speaker, Executive Director – Translational Medicine, Oric Pharmaceuticals

Great opportunity to meet colleagues of the same field from other companies as well as vendors to learn about their new offerings.

Past Attendee, Director, Pfizer

Explore the Full Event Agenda Now

40+ expert speakers sharing cutting-edge insights
12 hours of dedicated networking including 1-to-1 meetings and receptions
4 workshops and engagers with leading innovators
2 focused tracks covering discovery to adoption
Full information on attending stakeholders across pharma, biotech, diagnostics, academia, and advocacy

Download the Agenda